REDDY-DASATINIB

Product Overview

About REDDY-DASATINIB

REDDY-DASATINIB is a prescription medication containing the active ingredient DASATINIB (DASATINIB (S)-PROPYLENE GLYCOL), used to treat certain types of cancer, including Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs) with a specific genetic mutation.

Key Benefits & Uses

• Treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML)
• Treatment of gastrointestinal stromal tumors (GISTs) with a specific genetic mutation
• Management of disease progression in patients with CML or GISTs

Active Ingredient & Action

DASATINIB (DASATINIB (S)-PROPYLENE GLYCOL) is a tyrosine kinase inhibitor that works by blocking the activity of specific enzymes involved in the growth and spread of cancer cells. By inhibiting these enzymes, DASATINIB helps to slow or stop the growth of cancer cells, thereby reducing the size of tumors and alleviating symptoms associated with CML and GISTs.

Important Notes

REDDY-DASATINIB should only be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and administration instructions carefully to minimize the risk of side effects. Patients taking REDDY-DASATINIB should be closely monitored for signs of adverse reactions, such as liver damage, bleeding, or other serious health issues. Regular blood tests and medical check-ups are necessary to ensure the safe and effective use of this medication.